Showing 181 - 199 results of 199 for search '"pathologist"', query time: 0.08s Refine Results
  1. 181

    Brain Tumor Detection and Classification Using IFF-FLICM Segmentation and Optimized ELM Model by Suvashisa Dash, Mohammed Siddique, Satyasis Mishra, Demissie J. Gelmecha, Sunita Satapathy, Davinder Singh Rathee, Ram Sewak Singh

    Published 2024-01-01
    “…Brain tumor detection and classification have become challenging and time-consuming for domain-specific radiologists and pathologists in medical image analysis. So, automatic detection and classification are essential to reduce the time of diagnosis. …”
    Get full text
    Article
  2. 182

    Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UK by Philippe Taniere, Manuel Rodriguez-Justo, Naureen Starling, Wasat Mansoor, Thomas Bird, Martin Eatock

    Published 2025-02-01
    “…The results were then reviewed by the steering group to agree on any recommendations and conclusions.Results A total of 50 responses were received from consultant oncologists (n=25), pathologists (n=15), specialist oncology pharmacists (n=5) and specialist oncology nurses (n=5). …”
    Get full text
    Article
  3. 183

    “The impact of orthognathic surgery on articulation proficiency and speech intelligibility in skeletal Class III malocclusion: 18 months follow up” by Chaman Lal, Mukul Kumar, Sanjeev Verma, Vinay Kumar, Raj Kumar Verma, Satinder Pal Singh, Vidya Rattan, Sanjay Munjal

    Published 2024-07-01
    “…Three qualified and experienced speech and language pathologists evaluated articulation errors and intelligibility of speech samples. …”
    Get full text
    Article
  4. 184
  5. 185

    Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence by Wang Wenhui, Gong Yitang, Chen Bingxian, Guo Hualei, Wang Qiang, Li Jing, Jin Cheng, Gui Kun, Chen Hao

    Published 2024-12-01
    “…However, it is difficult to accurately and quantitatively evaluate the count of positive nucleus during the diagnosis process of pathologists, and the process is time-consuming and labor-intensive. …”
    Get full text
    Article
  6. 186
  7. 187

    Rare Site of an Inflammatory Myofibroblastic Tumor at the Epididymis: A Case Report by Lange A, Dominiak N, Petros FG

    Published 2025-01-01
    “…Patient recovered well with no reoccurrence at this time.Conclusion: Inflammatory myofibroblastic tumors recurrence rate is < 2%; however, some literature suggests higher depending on location and immunohistochemical profile. The expertise of pathologists, utilization of morphology, and immunohistological profile are all crucial in accurate diagnoses of these lesions. …”
    Get full text
    Article
  8. 188

    Inverse Relationship Between Leydig Cell Density and Metastatic Potential of Prostatic Adenocarcinoma by W. John Wang, Y. Albert Yeh, Paul Stout, Kang Fan

    Published 1999-01-01
    “…The means of cell counts by four pathologists, expressed as cell/0.78 mm2 were used for analysis. …”
    Get full text
    Article
  9. 189

    Prevalence and clinicopathological Spectrum of Auto-Immune Liver Diseases & Overlap syndrome by Annapoorani Varadarajan, Archana Rastogi, Rakhi Maiwall, Chhagan Bihari, Sherin Thomas, Vikrant Sood, Saggere Muralikrishna Shasthry

    Published 2023-07-01
    “…Clinical, demographic, and laboratory parameters were retrieved. Two pathologists independently reviewed the liver biopsies and reassessed 18 histopathological parameters. …”
    Get full text
    Article
  10. 190

    Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model by Arnold-Jan Kruse, Jan P. A. Baak, Emiel A. Janssen, Kjell-Henning Kjellevold, Bent Fianec, Kjell Lovslett, Johan Bergh, Stanley Robboy

    Published 2004-01-01
    “…Furthermore, it was studied whether subjective evaluation of the Ki67 sections by experienced pathologists, who were aware of the prognostic quantitative Ki67 features, could also predict the outcome. …”
    Get full text
    Article
  11. 191

    Morphological features of autoimmune gastritis by Ye. A. Losik, L. S. Selivanova, M. Yu. Konkov, T. L. Lapina, A. S. Tertychnyi, V. T. Ivashkin

    Published 2014-07-01
    “…According to guidelines of the Russian Society of Pathologists in all cases multiple biopsies have been taken at esophagogastroduodenoscopy. …”
    Get full text
    Article
  12. 192

    A Framework for Early Detection of Acute Lymphoblastic Leukemia and Its Subtypes From Peripheral Blood Smear Images Using Deep Ensemble Learning Technique by Sajida Perveen, Abdullah Alourani, Muhammad Shahbaz, M. Usman Ashraf, Isma Hamid

    Published 2024-01-01
    “…Furthermore, this provides references for pathologists and healthcare providers, aiding them in producing specific guidelines and more informed choices about patient and disease management.…”
    Get full text
    Article
  13. 193

    Pathological and radiological assessment of benign breast lesions with BIRADS IVc/V subtypes. should we repeat the biopsy? by Wesam Rjoop, Anwar Rjoop, Alia Almohtaseb, Lama Bataineh, Zeina Nser Joubi, Maha Gharaibeh, Abdalrahman Al-Qwabah, Yousef Alasheh, Ismail Matalka

    Published 2025-02-01
    “…The study recommends a correlation between clinical and radiological findings and encourages multidisciplinary decision-making among radiologists, pathologists, and clinicians to determine if a repeat biopsy is warranted. …”
    Get full text
    Article
  14. 194

    An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with... by Xiaodan Zheng, Yuanyuan Zheng, Yanlin Zhang, Jianlan Xie, Xiaojing Teng, Kuo Bi, Lan Sun, Xiaowen Huang, Mulan Jin, Xiaoge Zhou

    Published 2025-01-01
    “…Abstract Background The differential diagnosis between adult systemic EBV-positive T-cell lymphoproliferative disorders (EBV+ T-LPD) and angioimmunoblastic T-cell lymphoma (AITL) with multiple EBV infections is difficult, and distinguishing between the two has become a diagnostic challenge for pathologists. Given that the clinical treatment plans are different, an accurate diagnosis is a prerequisite to ensure effective treatment, therefore, it is extremely necessary and meaningful to find effective pathological indicators for distinguishing between two diseases. …”
    Get full text
    Article
  15. 195

    A Novel, Patient-Specific Mathematical Pathology Approach for Assessment of Surgical Volume: Application to Ductal Carcinoma in situ of The Breast by Mary E. Edgerton, Yao-Li Chuang, Paul Macklin, Wei Yang, Elaine L. Bearer, Vittorio Cristini

    Published 2011-01-01
    “…By obtaining these ratios at the time of initial biopsy, pathologists can employ our model to predict the size of the tumor and thereby inform surgeons how much tissue to remove (surgical volume). …”
    Get full text
    Article
  16. 196

    The Financial Implications of Pancreatic Surgery: The Hospital Is the Big Winner, Not the Surgeon! by Nitzan Zohar, MD, Avinoam Nevler, MD, Sean P. Maher, Matthew C. Rosenthal, Florence Williams, Wilbur B. Bowne, MD, FACS, Charles J. Yeo, MD, FACS, Harish Lavu, MD, FACS

    Published 2024-03-01
    “…The differences between the professional fee charges and receipts per patient were also considerable for other health care professionals such as anesthesiologists ($4945 charges vs $1406 receipts [28%]) and pathologists ($3035 charges vs $680 receipts [22%]). …”
    Get full text
    Article
  17. 197

    Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract by Mohammad Jad Moussa, Georges C. Tabet, Arlene O. Siefker‐Radtke, Lianchun Xiao, Nathaniel R. Wilson, Jianjun Gao, Christopher J. Logothetis, Petros Grivas, Byron Lee, Amishi Y. Shah, Pavlos Msaouel, Roger Li, Leticia Campos Clemente, Jianping Zhao, Nizar M. Tannir, Ashish M. Kamat, Donna E. Hansel, Charles C. Guo, Matthew T. Campbell, Omar Alhalabi

    Published 2025-01-01
    “…Histopathologic review was conducted by independent pathologists. Relapse event was the time‐to‐event outcome, and relapse probabilities were estimated using a competing risk method with cumulative incidence functions (CIFs). …”
    Get full text
    Article
  18. 198
  19. 199